# Charles River Laboratories (CRL) financials

Charles River Laboratories reported revenue of $4.02 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), down 0.9% from fiscal 2024. Net income was −$144 million and diluted earnings per share −$2.91.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 26 Sep 2026), revenue was $983 million, down 2.2% from a year earlier.

Source: Charles River Laboratories's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026. Amounts in USD. Page: https://aapwire.com/stocks/CRL. Retrieved 2026-11-16.

## Latest results: Q3 FY2026

Charles River Laboratories reported revenue of $983 million, down 2.2% from a year earlier, net income of $333 million and diluted earnings per share of $6.86 against $1.10 for the third quarter of fiscal 2026 (the three months to 26 Sep 2026).

From its quarterly report, filed 4 Nov 2026.

| Measure | Q3 FY2026 | Q3 FY2025 | Change |
| --- | ---: | ---: | ---: |
| Revenue | $982.7M | $1.00B | −2.2% |
| Gross profit | $357.9M | $338.8M | +5.6% |
| Gross margin | 36.4% | 33.7% | +2.7 pts |
| Operating income | $202.6M | $133.8M | +51.4% |
| Operating margin | 20.6% | 13.3% | +7.3 pts |
| Net income | $333.1M | $54.42M | +512% |
| Diluted EPS | $6.86 | $1.10 | +524% |
| Operating cash flow | $254.1M | $213.8M | +18.8% |
| Capital expenditure | $46.81M | $35.58M | +31.6% |
| Free cash flow | $207.3M | $178.2M | +16.3% |

Page: https://aapwire.com/stocks/CRL/earnings

## Annual figures (fiscal years)

| Measure | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $1.68B | $1.86B | $2.27B | $2.62B | $2.92B | $3.54B | $3.98B | $4.13B | $4.05B | $4.02B |
| Revenue growth | +23.3% | +10.5% | +22.0% | +15.7% | +11.5% | +21.1% | +12.3% | +3.9% | −1.9% | −0.9% |
| Gross profit | $1.40B | $1.57B | — | $958.3M | $1.07B | $1.33B | $1.46B | $1.50B | $1.33B | $1.32B |
| Operating income | $237.6M | $288.3M | $331.4M | $351.2M | $432.7M | $589.9M | $651.0M | $617.3M | $227.3M | $25.16M |
| Net income | $154.8M | $123.4M | $226.4M | $252.0M | $364.3M | $391.0M | $486.2M | $474.6M | $22.20M | −$144.3M |
| Diluted EPS | $3.23 | $2.54 | $4.62 | $5.07 | $7.20 | $7.60 | $9.48 | $9.22 | $0.20 | −$2.91 |
| Operating cash flow | $316.9M | $318.1M | $441.1M | $480.9M | $546.6M | $760.8M | $619.6M | $683.9M | $734.6M | $737.6M |
| Capital expenditure | $55.29M | $82.43M | $140.1M | $140.5M | $166.6M | $228.8M | $324.7M | $318.5M | $233.0M | $219.2M |
| Free cash flow | $261.6M | $235.6M | $301.1M | $340.4M | $380.0M | $532.0M | $294.9M | $365.4M | $501.6M | $518.5M |
| Gross margin | 83.5% | 84.4% | — | 36.6% | 36.7% | 37.7% | 36.8% | 36.4% | 32.9% | 33.0% |
| Operating margin | 14.1% | 15.5% | 14.6% | 13.4% | 14.8% | 16.7% | 16.4% | 14.9% | 5.6% | 0.6% |
| Net margin | 9.2% | 6.6% | 10.0% | 9.6% | 12.5% | 11.0% | 12.2% | 11.5% | 0.5% | −3.6% |
| Cash and equivalents | $117.6M | $163.8M | $195.4M | $238.0M | $228.4M | $241.2M | $233.9M | $276.8M | $194.6M | $213.8M |
| Total debt | $1.21B | $1.12B | $1.65B | $2.02B | $2.16B | $2.95B | $3.15B | $3.12B | $2.78B | $2.63B |
| Shareholders' equity | $836.8M | $1.05B | $1.32B | $1.63B | $2.11B | $2.53B | $2.98B | $3.60B | $3.46B | $3.16B |
| Diluted shares | 48.0M | 48.6M | 49.0M | 49.7M | 50.6M | 51.4M | 51.3M | 51.5M | 51.6M | 49.6M |

## Quarterly figures (last eight fiscal quarters)

| Measure | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $1.00B | $984.2M | $1.03B | $1.00B | $994.2M | $995.8M | $1.00B | $982.7M |
| Revenue, year on year | −1.1% | −2.7% | +0.6% | −0.5% | −0.8% | +1.2% | −2.7% | −2.2% |
| Gross margin | 28.4% | 32.3% | 34.6% | 33.7% | 31.1% | 29.6% | 36.2% | 36.4% |
| Operating income | −$167.7M | $74.67M | $100.1M | $133.8M | −$283.4M | $119.9M | $119.9M | $202.6M |
| Net income | −$214.5M | $25.47M | $52.33M | $54.42M | −$276.6M | −$14.84M | −$1.48M | $333.1M |
| Diluted EPS | −$4.20 | $0.50 | $1.06 | $1.10 | −$5.62 | −$0.30 | −$0.03 | $6.86 |
| Free cash flow | $83.75M | $112.4M | $169.3M | $178.2M | $58.57M | −$14.83M | $148.6M | $207.3M |

## Operating KPIs

| KPI | Latest | Period | Change on a year |
| --- | ---: | --- | --- |
| [Organic revenue (change on a year)](https://aapwire.com/stocks/CRL/kpi/organic-revenue-change-on-a-year) | 5.9% | quarter to 26 Sep 2026 | down 0.6 points |
| [Revenue](https://aapwire.com/stocks/CRL/kpi/revenue) | $995.8M | quarter to 28 Mar 2026 | up 1.2% |
| [Remaining performance obligations](https://aapwire.com/stocks/CRL/kpi/remaining-performance-obligations) | $675.3M | at 26 Sep 2026 | up 4.0% |
| [Cost of services provided (excluding amortization of intangible assets) revenue](https://aapwire.com/stocks/CRL/kpi/cost-of-services-provided-excluding-amortization-of-intangible-assets-revenue) | $780.3M | quarter to 26 Sep 2026 | down 3.4% |
| [Cost of products sold (excluding amortization of intangible assets) revenue](https://aapwire.com/stocks/CRL/kpi/cost-of-products-sold-excluding-amortization-of-intangible-assets-revenue) | $202.4M | quarter to 26 Sep 2026 | up 2.8% |
| [DSA revenue](https://aapwire.com/stocks/CRL/kpi/dsa-revenue) | $596.3M | quarter to 26 Sep 2026 | down 0.7% |
| [RMS revenue](https://aapwire.com/stocks/CRL/kpi/rms-revenue) | $207.5M | quarter to 26 Sep 2026 | down 2.8% |
| [Manufacturing revenue](https://aapwire.com/stocks/CRL/kpi/manufacturing-revenue) | $178.9M | quarter to 26 Sep 2026 | down 6.2% |
| [United States revenue](https://aapwire.com/stocks/CRL/kpi/united-states-revenue) | $541.7M | quarter to 26 Sep 2026 | up 0.8% |
| [Europe revenue](https://aapwire.com/stocks/CRL/kpi/europe-revenue) | $240.1M | quarter to 26 Sep 2026 | down 13.5% |
| [Canada revenue](https://aapwire.com/stocks/CRL/kpi/canada-revenue) | $120.6M | quarter to 26 Sep 2026 | up 3.2% |
| [Asia Pacific revenue](https://aapwire.com/stocks/CRL/kpi/asia-pacific-revenue) | $61.6M | quarter to 26 Sep 2026 | up 19.3% |

## Method

Each period is read from the report the company filed and checked against accounting identities; a figure that does not pass is left blank (—), never estimated. Free cash flow is operating cash flow less capital expenditure. Diluted EPS is as the company reported it, adjusted for later stock splits. Research information only, not investment advice.
